Niaid DCR FY26-27 operational task order
Ended Awarded Last action
- Contract number
- 75N91025F00012
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $137,656,019
Award facts
- Contract value 98% obligated
- $139,889,945.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $60,078,393 | |
| Exercise an Option | $10,193,922 | |
| Funding Only Action | $57,111,634 | |
| Original award | $10,272,070 |
About this award
The National Institute of Allergy and Infectious Diseases issued a $139.89 million delivery order to Leidos Biomedical Research Inc. on August 31, 2025, under the NIAID master indefinite delivery contract HHSN261201500003I for operational and research support services.
Place of performance is Frederick, Maryland. The order extends through August 30, 2027, and carries cost-plus-fixed-fee pricing with no set-aside. Leidos Biomedical Research operates as an FFRDC contractor delivering biomedical research execution, facilities infrastructure management, clinical trial support, and specialized manufacturing to NIH institutes. Under this order, the contractor provides infectious disease research and facility operations support across NIAID's research portfolio.
Service Contract Inventory reporting for FY2025 reflects $5 million invoiced against the order with 2.4 FTEs; the prime self-performed all reported hours without subcontractor engagement on SCI-reportable activity.
Quick answers
Who was awarded contract 75N91025F00012?
75N91025F00012 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2025.
How much is contract 75N91025F00012 worth?
The government has obligated $137,656,019 on 75N91025F00012. Its current value, with exercised options, is $139,889,945.
Which agency awarded contract 75N91025F00012?
National Cancer Institute (National Institutes of Health) awarded 75N91025F00012, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91025F00012 an order under another contract?
Yes. 75N91025F00012 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91025F00012 competed?
The extent of competition for 75N91025F00012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award